Safety of AZD1222 COVID-19 vaccine and low Incidence of SARS-CoV-2 infection in Botswana following ChAdOx1(AZD1222) vaccination: A single-arm open-label interventional study - final study results
Description
CONCLUSION: AZD1222 is safe, effective, and immunogenic for people living with and without HIV.